Monday, June 15, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 312 of 1,261

  1. US 11129858

    Compositions and methods for inhibiting seizures

    The Regents of the University of California · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  2. US 11129844

    Compositions and methods for modulating MECP2 expression

    Ionis Pharmaceuticals, Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  3. US 11129828

    Pyridazinone compounds and their use as DAAO inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  4. US 11129819

    Fumarate analogs and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  5. US 11129826

    Bupropion as a modulator of drug activity

    AXSOME THERAPEUTICS, INC. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  6. US 11129818

    Topical roflumilast formulation having improved delivery and plasma half life

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  7. US 11129810

    Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease

    MEREO BIOPHARMA 1 LIMITED · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  8. US 11129808

    PKC-delta-I inhibitor formulations and uses thereof

    THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERRANS AFFAIRS OFFICE OF THE GENERAL COUNSEL · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  9. US 11129805

    Dual ACE C-domain/NEP inhibitors

    ANGIODESIGN (UK) LIMITED · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  10. US 11129811

    Methods and compositions to prevent or treat bacterial infections

    The Board of Regents of the University of Texas System · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  11. US 11129791

    Drug delivery device

    Nano Precision Medical, Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  12. US 11129799

    Dual lane coating

    Aquestive Therapeutics, Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  13. US 11129790

    Chemo-enzymatic site-specific modification of peptides and proteins to form cleavable conjugates

    Northwestern University · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  14. US 11123431

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  15. US 11124901

    Composite fabric, method for forming composite fabric, and use of a composite matter fabric

    FIRST STEP HOLDINGS, LLC · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  16. US 11124768

    Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response

    Northwest Biotherapeutics, Inc. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  17. US 11124567

    Anti-TREM2 antibodies and methods of use thereof

    DENALI THERAPEUTICS INC. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  18. US 11124550

    Proteinaceous molecules and methods of use

    The Regents of the University of California · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  19. US 11124612

    Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation

    Northwestern University · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  20. US 11124542

    Modulators of melanocortin receptors

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  21. US 11124502

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  22. US 11124498

    Compositions and methods for modulating protease activity

    The Regents of the University of California · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  23. US 11124504

    Kappa opioid receptor antagonists and products and methods related thereto

    BLACKTHORN THERAPEUTICS, INC. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  24. US 11124493

    Nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.